Floatz logo

Losartan

Radiation-Induced Disorder

Massachusetts General HospitalSmall moleculePhase 2Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Radiation-Induced Disorder cohort.

Asset / SponsorPhaseRating
Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor) Fab Fragment (Human-Mouse Monoclonal Rhufab V2 1-Chain), Disulfide With Human-Mouse Monoclonal Rhufab V2 Light Chain
The New York Eye Cancer Center
Phase 4BBB
Corpril
Wake Forest University Health Sciences
Phase 2B
Ozurdex
Arman Mashayekhi
Phase 2CCC
Ivonescimab
Zhejiang Cancer Hospital
Phase 2CCC
[68ga]cbp8
Massachusetts General Hospital
Phase 2CCC

View all 13 →

Same molecule, other indications

Losartan is also rated in:

hypertensive disorderActive
BBB
Indicative · Phase 4
76 / 100
View asset →
cardiovascular disorderDormant
BB
Indicative · Phase 4
66 / 100
View asset →
psychotic disorderDormant
BB
Indicative · Phase 4
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →